Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin in Relapsed Cutaneous T-Cell Lymphoma
NCT00744991Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enzastaurin in cutaneous T-cell lymphoma (CTCL), sponsored by Eli Lilly and Company. Started Sep 2008; status: completed.
02
Drugs
enzastaurin
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00744991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744991.